| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...622763B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0022763 |
| P932 | PMC publication ID | 3144929 |
| P698 | PubMed publication ID | 21818385 |
| P5875 | ResearchGate publication ID | 51548944 |
| P50 | author | Helmut Jonuleit | Q30511642 |
| P2093 | author name string | Stephan Grabbe | |
| Kerstin Steinbrink | |||
| Edith Graulich | |||
| Nicole Bacher | |||
| P2860 | cites work | Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway | Q24310325 |
| Interleukin-12 and the regulation of innate resistance and adaptive immunity | Q29614602 | ||
| The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. | Q30445936 | ||
| Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells. | Q54656174 | ||
| CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity | Q56904531 | ||
| Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells | Q58180769 | ||
| Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities | Q60687739 | ||
| Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma | Q73850975 | ||
| Induction of tolerance by IL-10-treated dendritic cells | Q73873437 | ||
| Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions | Q74179201 | ||
| Interleukin 10 production by human melanoma | Q77557398 | ||
| A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response | Q80542447 | ||
| Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells | Q80800895 | ||
| APC activation by IFN-alpha decreases regulatory T cell and enhances Th cell functions | Q84126782 | ||
| Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses | Q84215298 | ||
| Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12. | Q33840997 | ||
| Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. | Q33862973 | ||
| Interferon-alpha in tumor immunity and immunotherapy | Q34568695 | ||
| Dendritic cell control of tolerogenic responses | Q34982085 | ||
| Cytokine therapeutics: lessons from interferon alpha | Q35033232 | ||
| The role of type I interferons in non-viral infections | Q35951793 | ||
| Cytokines in cancer immunity and immunotherapy | Q35951855 | ||
| Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection | Q35958851 | ||
| Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. | Q36011366 | ||
| Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. | Q36368488 | ||
| Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis | Q36726382 | ||
| How tumours escape mass destruction | Q37287162 | ||
| Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline | Q37644104 | ||
| Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. | Q37795583 | ||
| Prognostic significance of autoimmunity during treatment of melanoma with interferon | Q37833559 | ||
| Neuronal nitric oxide synthase modulates maturation of human dendritic cells | Q39710543 | ||
| Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation | Q39853571 | ||
| Melanoma epidemiology and trends. | Q40017236 | ||
| Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity | Q40349921 | ||
| Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy | Q40641266 | ||
| IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. | Q40811244 | ||
| Increased interleukin-10 serum levels in patients with solid tumours. | Q40936263 | ||
| Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. | Q40971390 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Prognostic significance of autoimmunity during treatment of melanoma with interferon. | Q44019499 | ||
| MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b | Q44122072 | ||
| IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells | Q44195895 | ||
| Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells | Q44927122 | ||
| Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1. | Q47731326 | ||
| Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function. | Q47841318 | ||
| Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-alpha | Q47969542 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | e22763 | |
| P577 | publication date | 2011-07-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells | |
| P478 | volume | 6 |
| Q57947090 | Functionalized Polystyrene Nanoparticles Trigger Human Dendritic Cell Maturation Resulting in Enhanced CD4+T Cell Activation |
| Q38646051 | Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone |
| Q51050849 | Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation |
| Q38937281 | Type I IFN gene delivery suppresses regulatory T cells within tumors |
| Q37498499 | Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters. |
Search more.